Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2011-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-010-1204-5PMID 20945089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phyllodes tumor of the breast: an update

  2010cited by this paper
• Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors

  2009cited by this paper
• Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours

  2009cited by this paper
• Chromosomal aberrations and genetic relations in benign, borderline and malignant phyllodes tumors of the breast: a comparative genomic hybridization study

  2008cited by this paper
• mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours

  2008cited by this paper
• A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra‐tumoral genetic heterogeneity and new genetic changes on recurrence

  2008cited by this paper
• Phyllodes tumors of the breast segregate in two groups according to genetic criteria

  2007cited by this paper
• HOXB13 promotes ovarian cancer progression

  2007cited by this paper
• Egfr Amplification Specific Gene Expression in Phyllodes Tumours of the Breast

  2007cited by this paper
• Suppression of invasive characteristics by antisense introduction of overexpressed HOX genes in ovarian cancer cells.

  2006cited by this paper
• Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression

  2006cited by this paper
• Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.

  2006cited by this paper
• Immunohistochemical expression of heparan sulfate correlates with stromal cell proliferation in breast phyllodes tumors

  2006cited by this paper
• Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast

  2005cited by this paper
• Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours

  2005cited by this paper
• A molecular classification of papillary renal cell carcinoma.

  2005influential reference
• Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data

  2005cited by this paper
• Phyllodes tumors of the breast: the role of pathologic parameters.

  2005influential reference
• HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation

  2005cited by this paper
• Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors.

  2005cited by this paper
• Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour

  2005cited by this paper
• Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death

  2005cited by this paper
• p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study

  2005cited by this paper
• Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases.

  2004cited by this paper
• Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

  2004cited by this paper
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations?

  2004cited by this paper
• Prognostic Evaluation of Proliferative Activity and DNA Content in the Phyllodes Tumor of the Breast: Immunohistochemical and Flow Cytometric Study of 118 Cases

  2004cited by this paper
• HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4.

  2004cited by this paper
• HOXB13 Induces Growth Suppression of Prostate Cancer Cells as a Repressor of Hormone-Activated Androgen Receptor Signaling

  2004cited by this paper
• HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4

  2004cited by this paper
• A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.

  2004cited by this paper
• Diminished transcription of chromosome arm 4q is inversely related to local spreading of hepatocellular carcinoma

  2004cited by this paper
• β‐catenin abnormalities and associated insulin‐like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast

  2003cited by this paper
• Malignant phyllodes tumours show stromal overexpression of c‐myc and c‐kit

  2003cited by this paper
• In vivo expression of the whole HOX gene network in human breast cancer.

  2003cited by this paper
• Deregulated homeobox gene expression in cancer: cause or consequence?

  2002cited by this paper
• The Wnt pathway, epithelial–stromal interactions, and malignant progression in phyllodes tumours

  2002cited by this paper
• Increased p53 Protein Expression in Malignant Mammary Phyllodes Tumors

  2002cited by this paper
• p53 protein expression and gene mutation in phyllodes tumors of the breast.

  2001cited by this paper
• Increased microvessel density in malignant and borderline mammary phyllodes tumours

  2001cited by this paper
• The treatment and prognosis of patients with phyllodes tumor of the breast: An analysis of 170 cases

  1996cited by this paper
• Gentleman R: R: A language for data analysis and graphics

  1996cited by this paper
• Hoxb-13: a new Hox gene in a distant region of the HOXB cluster maintains colinearity.

  1996cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper
• Cystosarcoma phyllodes. A clinicopathologic analysis of 42 cases

  1978cited by this paper
• Cystosarcoma phyllodes of the breast.

  1974cited by this paper

• Genomic Landscape and Therapeutic Implications of Metaplastic Breast Carcinoma: Insights from a Nationwide Database Including Diagnostic Mimickers.

  2026cites this paper
• Integrative multi-omics reveals common and distinct pathogenic mechanisms and preoperative diagnostic signatures in breast fibroepithelial lesions

  2025cites this paper
• A Comparative Study on Copy Number Variation in Subtypes of Breast Phyllodes Tumors

  2025cites this paper
• Molecular Pathobiology of Breast Fibroepithelial Tumours

  2025cites this paper
• A Comprehensive Analysis of HOXB13 Expression in Hepatocellular Carcinoma

  2024cites this paper
• Genomic Analysis of Advanced Phyllodes Tumors Using Next-Generation Sequencing and Their Chemotherapy Response: A Retrospective Study Using the C-CAT Database

  2024cites this paper
• Gene Expression Profiling of Fibroepithelial Lesions of the Breast

  2023cites this paper
• Refining the classification of breast phyllodes tumours.

  2023cites this paper
• Margin Status and Local Recurrence in Phyllodes Tumours of the Breast: A Canadian Series

  2022cites this paper
• Morphological features of 52 cases of breast phyllodes tumours with local recurrence

  2022cites this paper
• An integrative approach for exploring the nature of fibroepithelial neoplasms

  2022cites this paper
• HOXB13 facilitates hepatocellular carcinoma progression by activating AKT/mTOR signaling pathway.

  2022cites this paper
• Fibroepithelial tumours of the breast—a review

  2021cites this paper
• Skin-Reducing Mastectomy and Immediate Reconstruction for a Large Recurrent Borderline Phyllodes Tumor

  2021cites this paper
• A Case of Phyllodes Tumor of the Breast with Mixed Liposarcoma: Case Report and Literature Review

  2021influential citation
• OTT_A_298379 3003..3011

  2021influential citation
• Phyllodes tumor of the breast

  2020cites this paper
• Morphologic and genetic heterogeneity in breast fibroepithelial lesions—a comprehensive mapping study

  2020cites this paper
• Clinicopathologic Features of Phyllodes Tumor in Breast

  2020cites this paper
• Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breast

  2019influential citation
• Genomic characterisation of breast fibroepithelial lesions in an international cohort

  2019cites this paper
• Immunohistochemical expression of Ki-67, p53, and CD10 in phyllodes tumor and their correlation with its histological grade

  2019cites this paper
• Liposarcoma of the Breast after Phyllodes Tumor resection: Case Report

  2018influential citation
• A rare case of fungating phyllodes tumor of the breast

  2018cites this paper
• HOXB13 expression and promoter methylation as a candidate biomarker in gastric cancer.

  2018cites this paper
• Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast

  2017cites this paper
• Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways

  2017cites this paper
• Update on the diagnosis and management of malignant phyllodes tumors of the breast.

  2017cites this paper
• Fibroepithelial lesions; The WHO spectrum.

  2017cites this paper
• Phyllodes tumours of the breast: a consensus review

  2016cites this paper
• In phyllodes tumors of the breast expression of SPARC (osteonectin/BM40) mRNA by in situ hybridization correlates with protein expression by immunohistochemistry and is associated with tumor progression

  2016cites this paper
• Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification

  2016cites this paper
• Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates.

  2016cites this paper
• Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity

  2016cites this paper
• Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade

  2016influential citation
• Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management

  2016cites this paper
• Heterologous Liposarcomatous Differentiation in Malignant Phyllodes Tumor is Histologically Similar but Immunohistochemically and Molecularly Distinct from Well‐differentiated Liposarcoma of Soft Tissue

  2016cites this paper
• Molecular Pathology of Fibroepithelial Neoplasms of the Breast

  2015cites this paper
• Transformation of benign phyllodes to malignant phyllodes tumor

  2015cites this paper
• MicroRNAs are differentially deregulated in mammary malignant phyllodes tumour

  2015cites this paper
• Phyllodes tumor: diagnostic imaging and histopathology findings.

  2015cites this paper
• Total mastectomy for phyllodes malignant tumor in an elderly patient

  2014cites this paper
• Fungating malignant phyllodes tumor

  2014influential citation
• Ko-pengekspresan Reseptor Estrogen beta (ERβ) dan Aktin Otot Licin pada Tumor Filodes di Payudara: Suatu Kajian Tisu Mikroarai (The Co-expression of Estrogen Receptor beta (ERβ) and Smooth Muscle Actin in Phyllodes Tumour of Breast: A Tissue Microarray Study)

  2014cites this paper
• Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups

  2014cites this paper
• Immunohistochemical expression of homeoproteins Six1 and Pax3 in breast phyllodes tumours correlates with histological grade and clinical outcome

  2014cites this paper
• Total mastectomy for phyllodes malignant tumor in an elderly patient

  2014cites this paper
• Phyllodes Tumor: Correlation of imaging and histopathologic features

  2013cites this paper
• Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast.

  2013cites this paper
• Recent insights into the molecular pathogenesis of mammary phyllodes tumours

  2013cites this paper
• Stromal Matrix Metalloproteinase-14 Expression Correlates With the Grade and Biological Behavior of Mammary Phyllodes Tumors

  2012cites this paper
• Phyllodes tumor in the breast

  2012cites this paper
• Malignant Transformation of Benign Phyllodes to Malignant Phyllodes Tumor

  2012cites this paper
• [The important morphological parameters used to differentiate benign/malignant phyllodes tumors of the breast].

  2012cites this paper
• Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: novel markers in biological classification

  2012influential citation
• Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins

  2011cites this paper